Open access · CC-BY
via OpenAlex
New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity
Gi‐Su Oh, Hyungjin Kim, AiHua Shen, Su‐Bin Lee, Sei‐Hoon Yang, Hyeok Shim, Eun Young Cho, Kang‐Beom Kwon, Tae Hwan Kwak, Hong‐Seob So
BioMed Research International · 2016 · ▲ 49 citations
Abstract
Cisplatin is a widely used chemotherapeutic agent for the treatment of various tumors. In addition to its antitumor activity, cisplatin affects normal cells and may induce adverse effects such as ototoxicity, nephrotoxicity, and peripheral neuropathy. Various mechanisms such as DNA adduct formation, mitochondrial dysfunction(definition), oxidative stress, and inflammatory responses are closely associated with cisplatin-induced nephrotoxicity; however, the precise mechanism remains unclear. The cofactor nicotinamide adenine dinucleotide (NAD(+)) has emerged as a key regulator of cellular energy metabolism and homeostasis. Recent studies have demonstrated associations between disturbance in intracellular NAD(+) levels and clinical progression of various diseases through the production of reactive oxygen species and inflammation. Furthermore, we demonstrated that reduction of the intracellular NAD(+)/NADH ratio is critically involved in cisplatin-induced kidney damage through inflammation and oxidative stress and that increase of the cellular NAD(+)/NADH ratio suppresses cisplatin-induced kidney damage by modulation of potential damage mediators such as oxidative stress and inflammatory responses. In this review, we describe the role of NAD(+) metabolism in cisplatin-induced nephrotoxicity and discuss a potential strategy for the prevention or treatment of cisplatin-induced adverse effects with a particular focus on NAD(+)-dependent cellular pathways.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1155/2016/4048390
- Canonical
- link ↗
- Fetched
- 2026-06-16 MST
Cite this
APA
Oh, G., Kim, H., Shen, A., Lee, S., Yang, S., Shim, H., Cho, E.Y., Kwon, K., Kwak, T.H., & So, H. (2016). New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity. <em>BioMed Research International</em>. https://doi.org/10.1155/2016/4048390
Vancouver
Oh G, Kim H, Shen A, Lee S, Yang S, Shim H, et al. New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity. BioMed Research International. 2016. doi:10.1155/2016/4048390.
BibTeX
@article{gisu2016NewThe,
title = {New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity},
author = {Gi‐Su Oh and Hyungjin Kim and AiHua Shen and Su‐Bin Lee and Sei‐Hoon Yang and Hyeok Shim and Eun Young Cho and Kang‐Beom Kwon and Tae Hwan Kwak and Hong‐Seob So},
journal = {BioMed Research International},
year = {2016},
doi = {10.1155/2016/4048390},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · CC-BY
Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling
Communications Biology 2020
Open access · CC-BY
NAD+/NADH redox alterations reconfigure metabolism and rejuvenate senescent human mesenchymal stem cells in vitro
Current Opinion in Cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease
Current opinion in cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease.
Frontiers in Medicine 2021
Open access · CC-BY
NAD+ Homeostasis in Diabetic Kidney Disease
Frontiers in sports and active living 2026
Open access · OA